IMU-838 and Oseltamivir in the Treatment of COVID-19
NCT04516915
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
38
Enrollment
OTHER
Sponsor class
Conditions
Covid 19
Interventions
DRUG:
IMU-838
DRUG:
Oseltamivir
Sponsor
University Hospitals Coventry and Warwickshire NHS Trust
Collaborators
[object Object]
[object Object]
[object Object]